openPR Logo
Press release

A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drugs Against Branded Generic Drugs

09-11-2018 08:01 PM CET | Health & Medicine

Press release from: Precision Business Insights

Generic Drugs Market

Generic Drugs Market

Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.

The global generic drugs market is driven by the rise of various diseases, need for cost effective drugs for treatment, and government initiatives to increase the use of generic drugs. In addition, favorable regulatory policies, patent expiration of the branded drugs, and growth in biosimilars segment are expected to boost the generic market. However, lack of awareness about the availability of generic drugs, competition from branded generics and lack of price control are hampering the generic drugs market.

The global generic drugs market is divided into following categories-

Therapeutic area
Cardiovascular
CNS
Antibiotics
Oncology
Gastrointestinal
Hormones
Pain Management
Others
End-users
Hospital, retail, online pharmacies

And lastly on the basis of geographical regions, the global generic market have five major regions- North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America generic drugs market is growing due to availability of more number of generics, increase awareness about the generic drugs and favorable regulatory policies. In Europe region, the market is growing due to increased prevalence of chronic diseases, increase in investment on biosimilars, and increase awareness about generic drugs. Asia Pacific generic drugs market is expected to be fastest growing due to increased government initiatives and increase in awareness about generic drugs. While Latin America generic drugs market is also booming due to increased awareness, increased cases of chronic diseases and demand of generic drugs.

Some of the key market players in generic market are Mylan N.V. (U.S.), Sun Pharmaceutical Industries Limited (India), Teva Pharmaceutical Industries, Ltd. (Israel), Dr Reddy’s Laboratories (India), Novartis AG (Sandoz International GmbH) (Switzerland), Apotex Holdings Inc. (Canada), Endo International plc (U.S.), Pfizer Inc. (U.S.), Johnson & Johnson Services Inc., (Janssen Pharmaceutica) (U.S.), Lupin Limited (India), Merck & Co, Inc. (U.S.), Mitsubishi Tanabe Pharma (Japan), Momenta Pharmaceuticals (U.S.), Nexus Pharmaceuticals (U.S.), and Novo Nordisk (Denmark) to name a few. In 2017, Nexus Pharmaceuticals got U.S. FDA approval for the first generic version of Hospira’s Isuprel, for the treatment of bradycardia, heart block.

To improve their market position in generic drug market companies are adopting strategies like expanding their market presence through collaboration and entering into new markets. For instance, in 2017, Medical inhaler company Vectura Group PLC collaborated with Sandoz, a division of Novartis AG, to develop a generic version of an inhaler therapy for asthma and COPD (chronic obstructive pulmonary disease). Mergers and acquisitions are key strategies adopted by various market players. For instance, in 2016, Teva Pharmaceutical Industries Ltd Acquired Allergen’s generic business Actavis Generics.

For More Information: https://www.precisionbusinessinsights.com/market-reports/global-generic-drugs-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drugs Against Branded Generic Drugs here

News-ID: 1234184 • Views: 1927

More Releases from Precision Business Insights

Collimating Lens Market Growth, Industry Outlook And Opportunities
Precision Business Insights published a research report on “Collimating Lens Market By Light Source (LED, Laser, Others) By Material (Glass, Plastic, Others) By Wavelength (2,000) By End User (Automobile, Medical, LiDAR, Light and Display Measurement, Spectroscopy, Interferometry and Others) - Global/Region/Country Forecast to 2028”. Collimating is a technique for precisely aligning light in a parallel pattern. This guarantees that the light has a small spread as it propagates, which
Glycidyl Methacrylate Market Comprehensive Research Study, Status, Future And 20 …
Precision Business Insights published a research report on “Glycidyl Methacrylate Market by Application (Plastics, Adhesives and Polymer Coating) and by End-Users (Manufacturing Units and Packaging Units) - Global/Region/Country Forecast to 2028”. Glycidyl methacrylate (GMA) is a glycidol and methacrylic acid ester. It's a prominent monomer used in epoxy resin manufacture. GMA is also a high-purity, dual-functional monomer that works well in coatings and resins. The Glycidyl Methacrylate market
Ornithine-Transcarbamylase Deficiency Market Competitive Insights, Leading Playe …
Precision Business Insights published a research report on “Ornithine Transcarbamylase Deficiency Market By Product Type (DTX-301, SEL-313, SHP-641, PRX-OTC, Others) By End User (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) - Global/Region/Country Forecast to 2028”. Ornithine transcarbamylase dysfunction is a hereditary condition that causes ammonia to build up in the blood. It is recognised by the absence of the enzyme ornithine transcarbamylase, which can be full or partial (OTC).
Workforce Management Software Market 2022, Industry Analysis, Size, Share, Growt …
Precision Business Insights published a research report on “Workforce Management Software Market By Solution (Time and Attendance Management, Leave and Absence Management, Workforce Scheduling, Workforce Analytics and Others) By Deployment Type (On-Premises and Cloud) By Organization Size (Large Enterprises, Small and Medium-sized Enterprises) End User (Banking Financial Services and Insurance (BFSI), Telecom, Government, Consumer Goods and Retail, Manufacturing, Energy and Utilities, Transportation and Logistics, Healthcare and Life Sciences, Information Technology

All 5 Releases


More Releases for Generic

Generic Drugs Market - Global Competitive Analysis
Generic drugs market growth is buoyed by increasing number of patented expiries for drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S and Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Generic Drugs Market Trends 2025
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017
Global Generic Drugs Industry -Recent Study
In this report, we analyze the Generic Drugs industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price,
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems. At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems. At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of
Custom Software Development over Generic Application
In the world of Information Technology and computers, specially used for business, it is inevitable to have quality software immaterial of the type of business or the size of it. There is an evident shift from the preference of the general software applications that are difficult to handle and maneuver. End-Users don’t want to have supplementary features that they will never use. This is the primary reason for the increased